RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 99 filers reported holding RAPT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,422 | -47.8% | 206 | -36.6% | 0.00% | – |
| Q2 2023 | $6,555 | +18.1% | 325 | 0.0% | 0.00% | – |
| Q1 2023 | $5,549 | +38.7% | 325 | +62.5% | 0.00% | – |
| Q4 2022 | $4,000 | -20.0% | 200 | 0.0% | 0.00% | – |
| Q3 2022 | $5,000 | +25.0% | 200 | 0.0% | 0.00% | – |
| Q2 2022 | $4,000 | -99.0% | 200 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $401,000 | +4912.5% | 200 | 0.0% | 0.00% | – |
| Q4 2021 | $8,000 | +33.3% | 200 | 0.0% | 0.00% | – |
| Q3 2021 | $6,000 | -72.7% | 200 | -80.0% | 0.00% | – |
| Q1 2021 | $22,000 | +10.0% | 1,000 | 0.0% | 0.00% | – |
| Q4 2020 | $20,000 | +300.0% | 1,000 | +566.7% | 0.00% | – |
| Q3 2020 | $5,000 | +25.0% | 150 | 0.0% | 0.00% | – |
| Q2 2020 | $4,000 | +33.3% | 150 | 0.0% | 0.00% | – |
| Q1 2020 | $3,000 | – | 150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 2,680,621 | $49,189,395 | 17.79% |
| Euclidean Capital LLC | 432,900 | $7,943,715 | 6.97% |
| GREAT POINT PARTNERS LLC | 1,355,151 | $24,867,021 | 4.88% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 875,984 | $16,074,306 | 3.02% |
| Trustees of Columbia University in the City of New York | 80,580 | $1,478,643 | 2.64% |
| Perceptive Advisors | 2,291,608 | $42,051,007 | 1.24% |
| Cormorant Asset Management, LP | 650,000 | $11,928 | 0.79% |
| Alphabet Inc. | 540,270 | $9,913,955 | 0.55% |
| Redmile Group, LLC | 688,132 | $12,627,222 | 0.55% |
| Orbimed Advisors | 1,251,070 | $22,957,135 | 0.45% |